Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient

查看全文 作　　者：Charmaine D [1]Rochester;Oluwaranti [2]Akiyode

机构地区：[1]Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy;[2]Department of Pharmacy Practice and Science, Howard University College of Pharmacy

出　　处：《World Journal of Diabetes》索引2014年第5卷第3期,共11页

摘　　要：Type 2 diabetes mellitus is a metabolic disorder of deranged fat, protein and carbohydrate metabolism resulting in hyperglycemia as a result of insulin resistance and inadequate insulin secretion. Although a wide variety of diabetes therapies is available, yet limited efficacy, adverse effects, cost, contraindications, renal dosage adjustments, inflexible dosing schedules and weight gain significantly limit their use. In addition, many patients in the United States fail to meet the therapeutic HbA1c goal of < 7% set by the American Diabetes Association. As such new and emerging diabetes therapies with different mechanisms of action hope to address some of these drawbacks to improve the patient with type 2 diabetes. This article reviews new and emerging classes, including the sodium-glucosecotransporter-2 inhibitors, 11β-Hydroxysteroid dehydrogenase type 1 inhibitors, glycogen phosphorylase inhibitors; protein tyrosine phosphatase 1B inhibitors, G Protein-Coupled receptor agonists and glucokinase activators. These emerging diabetes agents hold the promise of providing benefit of glucose lowering, weight reduction, low hypoglycemia risk, improve insulin sensitivity, pancreatic β cell preservation, and oral formulation availability. However, further studies are needed to evaluate their safety profile, cardiovascular effects, and efficacy durability in order to determine their role in type 2 diabetes management. 关键词：TYPE 2 diabetes mellitus Sodium dependent glucose co-transporter 2 INHIBITORS 11β-Hydroxysteroid dehydrogenase TYPE 1 INHIBITORS Glycogen PHOSPHORYLASE INHIBITORS Protein tyrosine phosphatase 1B INHIBITORS G protein-coupled receptor agonists GLUCOKINASE ACTIVATORS

相关文献

参考文献（14）
引证文献（3）
耦合文献（6）

参考文献(14)

引证文献(3)

耦合文献(6)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient

参考文献(14)

引证文献(3)

耦合文献(6)

用户提示